Rigel Pharmaceuticals' Unattributed Round

Rigel Pharmaceuticals raised a round of funding on January 01, 1997.

Rigel Pharmaceuticals discovers and develops drugs for the treatment of inflammatory/ autoimmune diseases and cancer, as well as viral and metabolic diseases. Their research focuses on intracellular s…

Articles about Rigel Pharmaceuticals' Unattributed Round: